Stock Comparison
ABBV vs SNY
AbbVie Inc and Sanofi ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$102.81B
P/E (TTM)
123.6
19.1
Forward P/E
17.8
8.8
Price/Sales
7.1
2.2
Price/Book
50.5
1.2
EV/EBITDA
30.2
12.2
Dividend Yield
2.77%
0.00%
Profitability
Net Margin
5.79%
16.00%
Operating Margin
32.20%
20.00%
Return on Equity
62.30%
6.58%
Return on Assets
10.00%
4.67%
Growth (YoY)
Revenue Growth
12.40%
6.00%
Earnings Growth
-46.20%
-11.70%
Price & Risk
Beta
0.3
0.3
52-Week High
$253.35
$49.91
52-Week Low
$176.02
$40.89
Analyst Target
$254.38
$55.90
Compare ABBV and SNY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.